Resolvin D2-d5
CAT:
HY-121636S
HY-121636S
804-HY-121636S
Size:
10 μg (262.11 μM x 100 μL in Ethanol)
Price:
Ask
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Resolvin D2-d5
Description:
Resolvin D2-d5 is the deuterium labeled Resolvin D2. Resolvin D2 is a metabolite of docosahexaenoic acid (DHA), with anti-inflammatory, anti-infective activities. Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis. Resolvin D2 is a remarkably potent inhibitor of TRPV1 (IC50 = 0.1 nM) and TRPA1 (IC50 = 2 nM) in primary sensory neurons[1][2][3].Product Name Alternative:
RvD2-d5UNSPSC:
12352211Hazard Statement:
H302, H315, H319, H335Target:
TRP ChannelType:
Isotope-Labeled CompoundsRelated Pathways:
Membrane Transporter/Ion Channel; Neuronal SignalingField of Research:
Infection; Inflammation/Immunology; Neurological DiseaseConcentration:
262.11 µM * 100 μL in EthanolPurity:
99.0Solubility:
10 mM in DMSOSmiles:
[2H]C(C([2H])([2H])[2H])(/C=C\C[C@@H]([C@@H](/C=C/C=C/C=C\C=C\[C@H](C/C=C\CCC(O)=O)O)O)O)[2H]Molecular Formula:
C22H27D5O5Molecular Weight:
381.52Precautions:
H302, H315, H319, H335References & Citations:
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216. |[2]Siddiqui YD, et al. Resolvin D2 Induces Resolution of Periapical Inflammation and Promotes Healing of Periapical Lesions in Rat Periapical Periodontitis. Front Immunol. 2019 Feb 26;10:307.|[3]Spite M, et al. Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis. Nature. 2009 Oct 29;461 (7268) :1287-91.|[4]Park CK, et al. Resolvin D2 is a potent endogenous inhibitor for transient receptor potential subtype V1/A1, inflammatory pain, and spinal cord synaptic plasticity in mice: distinct roles of resolvin D1, D2, and E1.6. J Neurosci. 2011 Dec 14;31 (50) :18433-8.Shipping Conditions:
Blue IceStorage Conditions:
Solution, -20°C, 2 yearsScientific Category:
Isotope-Labeled CompoundsClinical Information:
No Development ReportedCAS Number:
[1881277-33-3]
